Stay updated on Selinexor Combo for High-Risk Myeloma Clinical Trial
Sign up to get notified when there's something new on the Selinexor Combo for High-Risk Myeloma Clinical Trial page.

Latest updates to the Selinexor Combo for High-Risk Myeloma Clinical Trial page
- Check3 days agoNo Change Detected
- Check10 days agoNo Change Detected
- Check17 days agoChange DetectedRevision: v3.3.3 was added to the history, and the page footer no longer mentions HHS Vulnerability Disclosure and Revision: v3.3.2.SummaryDifference0.2%

- Check24 days agoNo Change Detected
- Check38 days agoChange DetectedThe history shows a new site revision (v3.3.2) added and the prior revision (v3.3.1) removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check45 days agoChange DetectedA new site revision entry v3.3.1 has been added to the history, and the previous revision v3.2.0 has been removed.SummaryDifference0.1%

- Check53 days agoChange DetectedRemoved the site-wide notice about a lapse in government funding, which does not affect study data or page functionality. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.7%

- Check67 days agoChange DetectedMultiple versions show updates to Study Status, Recruitment Status, and Contacts/Locations. These changes reflect shifts in the trial's current state and the locations/points of contact for the study.SummaryDifference0.1%

- Check96 days agoChange DetectedUpdate adds a government-funding status notice and NIH Clinical Center operating details with a v3.2.0 revision, while removing the old v3.1.0 tag.SummaryDifference12%

Stay in the know with updates to Selinexor Combo for High-Risk Myeloma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Selinexor Combo for High-Risk Myeloma Clinical Trial page.